Trans aTTom A retrospective, prospective translational study to identify and validate biomarkers of late recurraence & adjuvant endocrine therapy benefit in women randomise in the aTTom study to 5 additional years of tamoxifen

Project: Research

Participants

  • Daniel Rea (Principal Investigator)
  • (Co-Investigator)

Colleges, School and Institutes

Short titleTrans aTTom A retrospective, prospective translational study to identify and validate biomarkers of late recurraence & adjuvant endocrine therapy benefit in women randomise in the aTTom study to 5 additional years of tamoxifen
StatusActive
Effective start/end date1/12/1530/06/21